fig1

Expression characteristics, immune signatures, and prognostic value of the KIF family members identified across cancers

Figure 1. The expression levels of KIF family members in various types of cancer were analyzed using different approaches. (A) The differential mRNA expression of KIFs in tumor and normal tissues was evaluated by combining data from the TCGA and GTEx databases. (B) Pan cancer data from the TCGA and GTEx databases show the levels of KIFs in tumor samples and corresponding non-cancerous samples. (C) Protein expression patterns of KIFs in different types of cancer were investigated using HPA data. 9D KIFs in tumor samples and corresponding non-cancerous samples are shown in the HPA data. (*P < 0.05, **P < 0.01, ***P < 0.001).

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/